PMCID: PMC9624240 DOI: 10.1161/CIRCULATIONAHA.122.061732 Packer M (2023): SGLT2 inhibitors: role in protective reprogramming of cardiac nutrient transport and metabolism
CMS.gov, Landscape Source Files Last accessed September 26, 2025 CMS.gov, Medicare Part C & D Performance Last accessed October 10, 2025 CMS.gov, Plan Benefits Package Last accessed October 15, 2025 CMS.gov, Monthly Enrollment by Contract/Plan/State/County Last accessed October 13, 2025 Learn more about how we use CMS data
The combination of mechanical unloading and direct cartilage protection is a powerful one-two punch that has a lot of orthopedic surgeons paying very close attention right now
In addition to renal outcomes, SGLT2 inhibitors also contribute to modest weight loss and blood pressure reduction
High costs, as well as tolerability issues, remain considerable barriers to a more wide-ranging prescribing of these drugs 1
S- [, ]300 , 60